Breast Cancer Research

official impact factor 5.79

Open Access Highly Access Email this article to a friend

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro

Richard S Finn*, Judy Dering, Dylan Conklin, Ondrej Kalous, David J Cohen, Amrita J Desai, Charles Ginther, Mohammad Atefi, Isan Chen, Camilla Fowst, Gerret Los and Dennis J Slamon

Breast Cancer Research 2009, 11:R77 doi:10.1186/bcr2419

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.